BIOGGIO, Switzerland--(BUSINESS WIRE)--The KD Pharma Group (“KD Pharma”) and its partner, SLA Pharma (“SLA”), announced that its new drug candidate EPAspire™ is shortly entering clinical trials as a ...
Update on investment management arrangements with Lloyds Banking Group and Scottish Widows On 15 February 2018, Standard Life Aberdeen plc ("SLA") announced that Lloyds Banking Group ("LBG") and ...
Standard Life Aberdeen plc ("SLA") is providing an update regarding the proposed sale of its UK and European insurance business ("Standard Life Assurance") to Phoenix Group (the "proposed transaction" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback